BioFocus DPI Enhances ADME/PK Laboratory Bioanalytical Capabilities
News Feb 27, 2009
BioFocus DPI has announced that it has strengthened its ADME/PK Laboratory bioanalytical capabilities through the installation of a Waters® Xevo™ TQ Mass Spectrometer. As one of the first European-based CROs to use this instrument, ADME/PK Laboratory enhances its ability to identify drug metabolites for customers.
The use of the Xevo™ TQ-MS combined with Waters UltraPerformance LC® (UPLC) technology increases BioFocus DPI ADME/PK Laboratory’s throughput and allows accurate measurements to both quantify and confirm the identity of metabolites in a wide range of biological fluids and tissues.
For molecules that would have a poor response using standard technologies, the Xevo™ TQ-MS will increase the likelihood of detection. In addition to bioanalysis, ADME/PK Laboratory offers high-quality services backed by expert consultancy - extending from discovery ADME to in vivo pharmacokinetics.
“We are building ADME/PK Laboratory’s advanced bioanalysis service to provide the best ADME data to support drug discovery programs for our UK, US and European clients,” said Chris Newton, SVP BioFocus DPI. “With this newly installed instrument providing greater sensitivity, accuracy and speed, we further enhance the service that we deliver - whether this is for a small scale study or as part of an integrated drug discovery program.”
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018